Gilead Sciences | GILD - Le Coût Des Ventes

Prix De L'Action
130.84
Variation Quotidienne
2.00 1.55%
Mensuellement
-6.12%
Annuel
26.72%
Q2 Prévisions
127.61




Le Coût Des Ventes Changement Date
AbbVie USD 4.22B 329M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
ALKERMES USD 46.21M 5.38M 2025-12
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Amgen USD 1.79B 128M 2025-12
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Coherus Biosciences USD 4.04M 324K 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Glaxosmithkline GBP 3.47B 461.37M 2025-12
Incyte USD 121.18M 22.18M 2025-12
J&J USD 8.07B 103M 2026-03
Merck USD 3.32B 531M 2025-12
Moderna USD 452M 245M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 3.67B 621M 2026-03
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12